Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1995 3
1998 9
1999 1
2000 4
2001 6
2002 6
2003 4
2004 1
2005 7
2006 2
2007 11
2008 7
2009 8
2010 9
2011 2
2012 6
2013 7
2014 3
2015 4
2016 6
2017 13
2018 6
2019 6
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

136 results
Results by year
Filters applied: . Clear all
Page 1
Scientific Advances and New Frontiers in Mesothelioma Therapeutics.
Mutti L, Peikert T, Robinson BWS, Scherpereel A, Tsao AS, de Perrot M, Woodard GA, Jablons DM, Wiens J, Hirsch FR, Yang H, Carbone M, Thomas A, Hassan R. Mutti L, et al. J Thorac Oncol. 2018 Sep;13(9):1269-1283. doi: 10.1016/j.jtho.2018.06.011. J Thorac Oncol. 2018. PMID: 29966799 Free PMC article. Review.
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification.
Tian K, Bakker E, Hussain M, Guazzelli A, Alhebshi H, Meysami P, Demonacos C, Schwartz JM, Mutti L, Krstic-Demonacos M. Tian K, et al. Among authors: mutti l. J Transl Med. 2018 Oct 13;16(1):282. doi: 10.1186/s12967-018-1650-0. J Transl Med. 2018. PMID: 30316293 Free PMC article.
Sirtuin Family Members Selectively Regulate Autophagy in Osteosarcoma and Mesothelioma Cells in Response to Cellular Stress.
Garva R, Thepmalee C, Yasamut U, Sudsaward S, Guazzelli A, Rajendran R, Tongmuang N, Khunchai S, Meysami P, Limjindaporn T, Yenchitsomanus PT, Mutti L, Krstic-Demonacos M, Demonacos C. Garva R, et al. Among authors: mutti l. Front Oncol. 2019 Sep 24;9:949. doi: 10.3389/fonc.2019.00949. eCollection 2019. Front Oncol. 2019. PMID: 31608237 Free PMC article.
Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
Fiorillo M, Lamb R, Tanowitz HB, Mutti L, Krstic-Demonacos M, Cappello AR, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Fiorillo M, et al. Among authors: mutti l. Oncotarget. 2016 Jun 7;7(23):34084-99. doi: 10.18632/oncotarget.9122. Oncotarget. 2016. PMID: 27136895 Free PMC article.
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment.
Guazzelli A, Meysami P, Bakker E, Demonacos C, Giordano A, Krstic-Demonacos M, Mutti L. Guazzelli A, et al. Among authors: mutti l. Int J Mol Sci. 2019 Jan 19;20(2):429. doi: 10.3390/ijms20020429. Int J Mol Sci. 2019. PMID: 30669483 Free PMC article.
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
Baird AM, Easty D, Jarzabek M, Shiels L, Soltermann A, Klebe S, Raeppel S, MacDonagh L, Wu C, Griggs K, Kirschner MB, Stanfill B, Nonaka D, Goparaju CM, Murer B, Fennell DA, O'Donnell DM, Barr MP, Mutti L, Reid G, Finn S, Cuffe S, Pass HI, Opitz I, Byrne AT, O'Byrne KJ, Gray SG. Baird AM, et al. Among authors: mutti l. Front Endocrinol (Lausanne). 2019 Feb 26;10:89. doi: 10.3389/fendo.2019.00089. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30863365 Free PMC article.
The Biochemical Role of the Human NEIL1 and NEIL3 DNA Glycosylases on Model DNA Replication Forks.
Albelazi MS, Martin PR, Mohammed S, Mutti L, Parsons JL, Elder RH. Albelazi MS, et al. Among authors: mutti l. Genes (Basel). 2019 Apr 23;10(4):315. doi: 10.3390/genes10040315. Genes (Basel). 2019. PMID: 31018584 Free PMC article.
Targeting hypoxic response for cancer therapy.
Paolicchi E, Gemignani F, Krstic-Demonacos M, Dedhar S, Mutti L, Landi S. Paolicchi E, et al. Among authors: mutti l. Oncotarget. 2016 Mar 22;7(12):13464-78. doi: 10.18632/oncotarget.7229. Oncotarget. 2016. PMID: 26859576 Free PMC article. Review.
Immunotherapy advances for mesothelioma treatment.
Bakker E, Guazzelli A, Ashtiani F, Demonacos C, Krstic-Demonacos M, Mutti L. Bakker E, et al. Among authors: mutti l. Expert Rev Anticancer Ther. 2017 Sep;17(9):799-814. doi: 10.1080/14737140.2017.1358091. Epub 2017 Jul 31. Expert Rev Anticancer Ther. 2017. PMID: 28724330 Review.
Anti-CTLA-4 therapy for malignant mesothelioma.
Guazzelli A, Bakker E, Krstic-Demonacos M, Lisanti MP, Sotgia F, Mutti L. Guazzelli A, et al. Among authors: mutti l. Immunotherapy. 2017 Mar;9(3):273-280. doi: 10.2217/imt-2016-0123. Immunotherapy. 2017. PMID: 28231719 Review.
136 results
Jump to page
Feedback